Table 2

End points of component trials of USCP

Trial	Primary end point	Other end points
Mild	Progression of CHF^4-150	LVEF^4-150, NYHA class^4-150, HF score^4-150, global assessment^4-150, QoL, 9 min SPT, heart size on CXR (death^4-150)
Moderate (MOCHA)	6 min walk 9 min SPT	LVEF^4-150, CHF hospitalisation^4-150, (QoL, global assessment, death^4-150)
Moderate (PRECISE)	6 min walk^4-150 9 min SPT	Global assessment^4-150, NYHA class^4-150, LVEF^4-150, QoL, CV hospitalisation^4-150
Severe	QoL	Death, CV hospitalisation, global assessment^4-150, NYHA class, LVEF^4-150, 6 min walk

↵4-150 Significant, between group, difference; CV, cardiovascular; CXR, chest radiography; HF, heart failure score; QoL, quality of life; SPT, self powered treadmill; for rest of key see text.